MapLight Therapeutics, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| – | +132.1% | +49.8% | +250.2% | |
| – | +161.0% | +37.1% | +183.3% | |
| – | +188.3% | -52.0% | +22.2% | |
| – | +188.3% | +36.4% | +180.4% | |
| – | +8.7% | +7.9% | -2.7% | |
| – | +16.7% | +8.3% | +1.9% | |
| – | +42.2% | +57.2% | +14.5% | |
| – | -9.6% | -41.2% | +72.0% | |
| – | +241.6% | +61.6% | +297.9% | |
| – | – | – | – | |
| – | +0.0% | +0.0% | +6.3% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.